GSK Investigational Site

Porta Westfalica, North Rhine-Westphalia 32457

0 studies enrolling now · 2 studies all time

What they study most

Lung Cancer, Non-Small Cell, Neoplasms, Breast

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed